IL94361A - Polypeptides, recombinant AND molecules and a method for the production of human hemoglobin-like protein - Google Patents

Polypeptides, recombinant AND molecules and a method for the production of human hemoglobin-like protein

Info

Publication number
IL94361A
IL94361A IL9436190A IL9436190A IL94361A IL 94361 A IL94361 A IL 94361A IL 9436190 A IL9436190 A IL 9436190A IL 9436190 A IL9436190 A IL 9436190A IL 94361 A IL94361 A IL 94361A
Authority
IL
Israel
Prior art keywords
globin
alpha
beta
hemoglobin
plasmid
Prior art date
Application number
IL9436190A
Other languages
English (en)
Hebrew (he)
Other versions
IL94361A0 (en
Original Assignee
Somatogenetics Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somatogenetics Int filed Critical Somatogenetics Int
Publication of IL94361A0 publication Critical patent/IL94361A0/xx
Publication of IL94361A publication Critical patent/IL94361A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6445—Haemoglobin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL9436190A 1989-05-10 1990-05-10 Polypeptides, recombinant AND molecules and a method for the production of human hemoglobin-like protein IL94361A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34962389A 1989-05-10 1989-05-10
US37416189A 1989-06-30 1989-06-30
US37911689A 1989-07-13 1989-07-13

Publications (2)

Publication Number Publication Date
IL94361A0 IL94361A0 (en) 1991-03-10
IL94361A true IL94361A (en) 1995-07-31

Family

ID=27407902

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9436190A IL94361A (en) 1989-05-10 1990-05-10 Polypeptides, recombinant AND molecules and a method for the production of human hemoglobin-like protein

Country Status (18)

Country Link
EP (3) EP1380645A2 (fr)
JP (1) JP3013902B2 (fr)
KR (1) KR920701434A (fr)
AT (2) ATE142692T1 (fr)
AU (1) AU635744B2 (fr)
CA (1) CA2050601C (fr)
DE (2) DE69034091T2 (fr)
DK (1) DK0402300T3 (fr)
ES (2) ES2204926T3 (fr)
FI (2) FI105104B (fr)
GR (1) GR3021106T3 (fr)
HU (1) HUT61591A (fr)
IE (1) IE970086A1 (fr)
IL (1) IL94361A (fr)
NO (2) NO304027B1 (fr)
NZ (1) NZ233642A (fr)
SG (1) SG47987A1 (fr)
WO (1) WO1990013645A1 (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022849A (en) * 1987-05-16 2000-02-08 Baxter Biotech Technology Saarl Mutant recombinant hemoglobins containing heme pocket mutations
US6204009B1 (en) 1988-05-16 2001-03-20 BAXTER BIOTECH TECHNOLOGY SàRL Nucleic acids encoding mutant recombinant hemoglobins containing heme pocket mutations
US6150506A (en) * 1989-05-10 2000-11-21 Baxter Biotech Technology Sarl Modified hemoglobin-like compounds and methods of purifying same
US5545727A (en) * 1989-05-10 1996-08-13 Somatogen, Inc. DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin
US5844090A (en) * 1994-05-09 1998-12-01 Somatogen, Inc. Modified hemoglobin-like compounds
US5599907A (en) * 1989-05-10 1997-02-04 Somatogen, Inc. Production and use of multimeric hemoglobins
WO1991013158A1 (fr) * 1990-02-28 1991-09-05 Delta Biotechnology Limited Production de proteines dans la levure
US6172039B1 (en) 1990-04-16 2001-01-09 Apex Bioscience, Inc. Expression of recombinant hemoglobin and hemoglobin variants in yeast
DE69133089T2 (de) * 1990-04-16 2003-04-17 Apex Bioscience, Inc. Expression von rekombinantem hämoglobin in hefe
US5610137A (en) * 1990-12-20 1997-03-11 The Uab Research Foundation Transgenic, cross-linked hemoglobin
EP0668909B1 (fr) * 1990-12-20 2001-10-10 The University Of Alabama Research Foundation Hemoglobine transgenique reticulee
US5714345A (en) * 1990-12-24 1998-02-03 Pharmaceutical Proteins Limited Increased expression of a gene by a second transferred mammary gland specific sequence transgenic
GB9028062D0 (en) * 1990-12-24 1991-02-13 Agricultural & Food Res Production of transgenic animals
WO1993008831A1 (fr) * 1991-10-30 1993-05-13 Strohtech, Inc. Expression d'hemoglobine recombinee et de variants d'hemoglobine recombines dans des levures
ATE168014T1 (de) * 1991-11-08 1998-07-15 Somatogen Inc Hämoglobine als arzneimittelabgabesystem
FR2688784B1 (fr) * 1992-03-18 1995-06-30 Pasteur Merieux Serums Vacc Transporteur d'oxygene.
US6610654B2 (en) 1993-03-31 2003-08-26 Wellstat Therapeutics Corporation Inhibitor of stem cell proliferation and uses thereof
US5939391A (en) * 1993-03-31 1999-08-17 Pro-Neuron, Inc. Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
UA40613C2 (uk) * 1993-03-31 2001-08-15 Про-Нейрон, Інк. Поліпептид, що має активність інгібітора проліферації стовбурових клітин(варіанти), фармацевтична композиція (варіанти), фармацевтична композиція для інгібування ділення стовбурових клітин у ссавців, фармацевтична композиція для лікування захворювань,які включають гіперпроліферативні стани, фармацевтична композиція для диференціального захисту нормальних стовбурових клітин, відмінних від лейкозних, спосіб очистки поліпептиду
US5554638A (en) * 1993-05-24 1996-09-10 Duke University Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
US5612310A (en) * 1993-05-24 1997-03-18 Duke University Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
US5840851A (en) * 1993-07-23 1998-11-24 Plomer; J. Jeffrey Purification of hemoglobin
US5665869A (en) * 1993-11-15 1997-09-09 Somatogen, Inc. Method for the rapid removal of protoporphyrin from protoporphyrin IX-containing solutions of hemoglobin
US6140071A (en) * 1994-01-27 2000-10-31 Somatogen, Inc. Proteins with mutations to decrease N-terminal methylation
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
WO1997004110A1 (fr) * 1995-07-14 1997-02-06 Somatogen, Inc. Procedes d'accroissement de l'expression de proteines
US5824511A (en) * 1995-08-01 1998-10-20 University Technology Corporation Method for enhancing the production of hemoproteins
US6812207B1 (en) 1995-10-23 2004-11-02 William Marsh Rice University Hemoglobin mutants that reduce heme loss
CA2231245A1 (fr) * 1995-10-23 1997-05-01 Mark S. Hargrove Mutants d'hemoglobine reduisant la perte d'hemes
CA2236794A1 (fr) * 1995-11-30 1997-06-05 Bruce A. Kerwin Methode de regulation de fonctionnalite au cours de la reticulation des hemoglobines
WO1997023631A2 (fr) * 1995-12-22 1997-07-03 Somatogen, Inc. Globines incluant des domaines de liaison
AU715914B2 (en) 1995-12-22 2000-02-10 Baxter Biotech Technology S.A.R.L. Globins containing binding domains
US5861483A (en) 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
US6136565A (en) * 1996-10-18 2000-10-24 Baxter Biotech Technology Sarl Methods of reducing the levels of protoporphyrin IX in recombinant hemoglobin preparations
EP1950298A3 (fr) 1997-05-02 2008-12-24 Baxter Biotech Technology S.A.R.L. Mutants d'hémoglobine dotés d'une expression soluble accrue et/ou d'une évacuation réduite de l'oxyde nitrique
DE10036491A1 (de) * 2000-07-25 2002-02-07 Roche Diagnostics Gmbh Expression von Alkalischer Phosphatase in Hefe
MXPA03008022A (es) 2001-03-09 2003-12-04 Genentech Inc Proceso para la produccion de polipeptidos.
US7504377B2 (en) 2006-10-23 2009-03-17 Ikor, Inc. Nitric oxide-blocked cross-linked tetrameric hemoglobin
US7494974B2 (en) 2006-10-24 2009-02-24 Ikor, Inc. Carboxymethylated cross-linked tetrameric hemoglobin
US20100204128A1 (en) * 2007-07-24 2010-08-12 Sanare Investment As Novel peptides
EP2058398A1 (fr) * 2007-11-09 2009-05-13 Nipro Corporation Production d'hémoglobine humaine recombinante à l'aide de levure Pichia
KR101584540B1 (ko) * 2014-04-16 2016-01-14 박병용 대형 식품용기 자동 세척장치
US10752672B1 (en) * 2019-02-01 2020-08-25 Cheer Global Limited Recombinant hemoglobins and methods of preparation and use thereof
US20230073947A1 (en) * 2020-01-10 2023-03-09 Intron Biotechnology, Inc. A method for preparing bovine myoglobin using escherichia coli
KR20220137895A (ko) * 2020-01-10 2022-10-12 주식회사 인트론바이오테크놀로지 대장균을 사용한 돼지 미오글로빈의 제조 방법
CN116203144B (zh) * 2022-05-11 2023-10-27 重庆医科大学附属儿童医院 测定血红蛋白中各型珠蛋白链比率的方法及其应用
CN118108834A (zh) * 2022-11-30 2024-05-31 康码（上海）生物科技有限公司 重组血红蛋白

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3924943A (en) 1974-06-11 1975-12-09 Xerox Corp Segmented biased transfer member
US4769326A (en) 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
US4511503A (en) 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4599197A (en) 1982-12-22 1986-07-08 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4512922A (en) 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4620948A (en) 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
GB8412517D0 (en) 1984-05-16 1984-06-20 Nagai K Recombinant fusion proteins
US4600531A (en) 1984-06-27 1986-07-15 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4598064A (en) 1984-06-27 1986-07-01 University Of Iowa Research Foundation Alpha-alpha cross-linked hemoglobins
US4774180A (en) 1986-02-26 1988-09-27 Massachusetts Institute Of Technology Construction and application of polyproteins
US4704692A (en) 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
GB8701001D0 (en) 1987-01-19 1987-02-18 Gordon D G Ceiling tiles
WO1988006601A1 (fr) 1987-03-02 1988-09-07 Genex Corporation Represseurs de genes
GB8711614D0 (en) * 1987-05-16 1987-06-24 Medical Res Council Proteins
EP0561245A1 (fr) * 1987-05-16 1993-09-22 Somatogenetics International, Inc. Produits de remplacement du sang comprenant d'hémoglobine recombinante

Also Published As

Publication number Publication date
WO1990013645A1 (fr) 1990-11-15
GR3021106T3 (en) 1996-12-31
EP0402300A2 (fr) 1990-12-12
HU905111D0 (en) 1992-02-28
JP3013902B2 (ja) 2000-02-28
NO304027B1 (no) 1998-10-12
NO973848L (no) 1997-08-21
DE69028448D1 (de) 1996-10-17
DE69028448T2 (de) 1997-02-06
ES2093640T3 (es) 1997-01-01
EP0700997B1 (fr) 2003-07-30
DK0402300T3 (da) 1996-09-30
CA2050601A1 (fr) 1990-11-11
EP0402300B1 (fr) 1996-09-11
FI105104B (fi) 2000-06-15
AU5675690A (en) 1990-11-29
IL94361A0 (en) 1991-03-10
JPH05503627A (ja) 1993-06-17
FI915279A0 (fi) 1991-11-08
ES2204926T3 (es) 2004-05-01
FI20000025A (fi) 2000-01-05
EP0402300A3 (fr) 1991-01-30
CA2050601C (fr) 2000-09-19
EP0700997A1 (fr) 1996-03-13
FI107938B (fi) 2001-10-31
NO914387D0 (no) 1991-11-08
NO914387L (no) 1991-11-08
SG47987A1 (en) 1998-04-17
NZ233642A (en) 1992-12-23
NO315568B1 (no) 2003-09-22
KR920701434A (ko) 1992-08-11
EP1380645A2 (fr) 2004-01-14
HUT61591A (en) 1993-01-28
AU635744B2 (en) 1993-04-01
DE69034091D1 (de) 2003-09-04
NO973848D0 (no) 1997-08-21
ATE246246T1 (de) 2003-08-15
DE69034091T2 (de) 2004-04-22
ATE142692T1 (de) 1996-09-15
IE970086A1 (en) 2000-02-23

Similar Documents

Publication Publication Date Title
AU635744B2 (en) Production in bacteria and yeast of hemoglobin and analogues thereof
US6274331B1 (en) Method of determining a functional linker for fusing globin subunts
US5599907A (en) Production and use of multimeric hemoglobins
US6828125B1 (en) DNA encoding fused di-alpha globins and use thereof
JP3390990B2 (ja) 血清ヒトアルブミン，製剤及び利用
SK279041B6 (sk) Konštrukt dna, transformovaná bunka a spôsob výrob
ZA200703235B (en) Polypeptides with a signal sequence comprising an fivsi motif and olynucleotides encoding therefor
US5734014A (en) Elafin derivative
US5844090A (en) Modified hemoglobin-like compounds
WO1991013158A1 (fr) Production de proteines dans la levure

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void